Department of Otolaryngology, Northwick Park Hospital, London, UK.
Clin Otolaryngol. 2011 Aug;36(4):306-12. doi: 10.1111/j.1749-4486.2011.02332.x.
To evaluate the diagnostic performance of half-Fourier-acquisition single-shot turbo-spin-echo (HASTE) diffusion-weighted magnetic resonance imaging in the detection, localisation and prediction of extent of cholesteatoma following canal wall up mastoid surgery.
Prospective blinded observational study.
University affiliated teaching hospital.
Forty-eight patients undergoing second-look surgery after previous canal wall up mastoid surgery for primary acquired cholesteatoma.
All patients underwent non-echo planar HASTE diffusion-weighted imaging prior to being offered 'second-look' surgery.
Radiological findings were correlated with second-look intra-operative findings in 38 cases with regard to presence, location and maximum dimensions of cholesteatoma.
Half-Fourier-acquisition single-shot turbo-spin-echo diffusion-weighted imaging accurately predicted the presence of cholesteatoma in 23 of 28 cases, and it correctly excluded in nine of 10 cases. Five false negatives were caused by keratin pearls of <2 mm and in one case 5 mm. Overall sensitivity and specificity for detection of cholesteatoma were 82% (95% confidence interval [CI] 62-94%) and 90% (CI 55-100%), respectively. Positive predictive value and negative predictive value were 96% (CI 79-100%) and 64% (CI 35-87%), respectively. Overall accuracy for detection of cholesteatoma was 84% (CI 69-94%). Half-Fourier-acquisition single-shot turbo-spin-echo diffusion-weighted imaging has good performance in localising cholesteatoma to a number of anatomical sub-sites within the middle ear and mastoid (sensitivity ranging from 75% to 88% and specificity ranging from 94% to 100%). There was no statistically significant difference in the size of cholesteatoma detected radiologically and that found during surgery (paired t-test, P = 0.16). However, analysis of size agreement suggests possible radiological underestimation of size when using HASTE diffusion-weighted imaging (mean difference -0.6 mm, CI -5.3 to 4.6 mm).
Half-Fourier-acquisition single-shot turbo-spin-echo diffusion-weighted imaging performs reasonably well in predicting the presence and location of postoperative cholesteatoma but may miss small foci of disease and may underestimate the true size of cholesteatoma.
评估半傅里叶采集单次激发涡轮自旋回波(HASTE)弥散加权磁共振成像在检测、定位和预测经完壁式乳突切开术后胆脂瘤的范围方面的诊断性能。
前瞻性盲法观察性研究。
大学附属教学医院。
48 例因原发性获得性胆脂瘤行完壁式乳突切开术后再次接受手术的患者。
所有患者均在接受“再次探查”手术前接受非回波平面 HASTE 弥散加权成像。
在 38 例患者中,将放射学发现与再次探查术中发现进行相关性分析,以确定胆脂瘤的存在、位置和最大尺寸。
半傅里叶采集单次激发涡轮自旋回波弥散加权成像在 28 例中的 23 例中准确预测了胆脂瘤的存在,在 10 例中的 9 例中正确排除了胆脂瘤的存在。5 例假阴性是由于 <2 mm 的角化珠和 1 例 5 mm 的角化珠引起的。胆脂瘤检测的总体敏感性和特异性分别为 82%(95%置信区间[CI]为 62%94%)和 90%(CI 为 55%100%)。阳性预测值和阴性预测值分别为 96%(CI 为 79%100%)和 64%(CI 为 35%87%)。胆脂瘤检测的总体准确性为 84%(CI 为 69%94%)。半傅里叶采集单次激发涡轮自旋回波弥散加权成像在将胆脂瘤定位于中耳和乳突的多个解剖亚部位方面具有良好的性能(敏感性范围为 75%88%,特异性范围为 94%~100%)。影像学检测到的胆脂瘤大小与术中发现的大小之间无统计学显著差异(配对 t 检验,P = 0.16)。然而,大小一致性分析表明,使用 HASTE 弥散加权成像可能会低估胆脂瘤的大小(平均差值为-0.6 mm,CI 为-5.3 至 4.6 mm)。
半傅里叶采集单次激发涡轮自旋回波弥散加权成像在预测术后胆脂瘤的存在和位置方面表现良好,但可能会遗漏小病灶,并且可能会低估胆脂瘤的真实大小。